FEATURED
FDA Approves Merck’s VAXNEUVANCE™ Pneumococcal 15-valent Conjugate Vaccine
Merck, also known as MSD, revealed that the U.S. Food and Drug Administration (FDA) has authorised VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate
DEALS
Arvinas and Pfizer to Co-develop and Commercialize Breast Cancer Therapy
Arvinas and Pfizer have announced a global collaboration to develop and commercialize ARV-471, an investigational oral PROTAC® (PROteolysis TArgeting Chimera)
PRESS RELEASES
EUCODIS to Develop New Microbial Enzymes for Eco-friendly Consumer Products
EUCODIS Bioscience will be developing new microbial enzymes for generating eco-friendly and innovative consumer products, such as detergents, textiles and
Comments & Analysis
Machine Learning Tissue Classifiers Power AI in Clinical Research
Machine learning tissue classifiers are one of the most powerful and promising AI-based clinical research solutions for all types of
RESOURCES
Download the latest pharmaceutical case studies, white papers, research papers and product brochures
Phospholipase D – Data Sheet
Phospholipase D EPLD040 is spray-dried from 50 mM potassium phosphate, 200 mM NaCl, pH 6.0. A EUCODIS Bioscience Data Sheet
LATEST PROJECTS
cGMP Plasmid DNA Manufacturing Facility, Thermo Fisher, California, USA
Thermo Fisher Scientific Inc., the global leader in serving science, has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad,
CLINICAL TRIALS
University of Oxford Starts Phase I Clinical Trial of Novel HIV Vaccine
The University of Oxford has commenced a Phase I clinical trial of a novel HIV vaccine candidate with vaccinations underway
REGULATORY
FDA Approves Merck’s VAXNEUVANCE™ Pneumococcal 15-valent Conjugate Vaccine
Merck, also known as MSD, revealed that the U.S. Food and Drug Administration (FDA) has authorised VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate
